Benign causes of 18-FDG uptake on whole body imaging
- 31 October 1998
- journal article
- review article
- Published by Elsevier BV in Seminars in Nuclear Medicine
- Vol. 28 (4), 352-358
- https://doi.org/10.1016/s0001-2998(98)80038-x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Diffuse F-18 FDG Uptake in Chronic ThyroiditisClinical Nuclear Medicine, 1997
- Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretationSeminars in Nuclear Medicine, 1996
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996
- Cost-effectiveness of PET imaging in clinical oncologyNuclear Medicine and Biology, 1996
- Preoperative identification of benign versus malignant parotid masses: A comparative study including positron emission tomographyThe Laryngoscope, 1995
- Salivary gland tumors: pretherapy evaluation with PET.Radiology, 1994
- Sequential Positron Emission Tomographic Evaluations of Brain Metabolism in Acute Herpes EncephalitisJournal of Neuroimaging, 1994
- Discordance Between F-18 Fluorodeoxyglucose Uptake and Contrast Enhancement in a Brain AbscessClinical Nuclear Medicine, 1993
- FDG-PET in the Selection of Brain Lesions for BiopsyJournal of Computer Assisted Tomography, 1991
- Pituitary microadenomas: a PET study.Radiology, 1990